Cleidocranial Dysplasia (CCD): From Genotype to Phenotype and Considerations for Care
Status
Conditions
Treatments
Details and patient eligibility
About
Cleidocranial Dysplasia (CCD) is a rare, autosomal dominant disorder characterized by dysplasia of bones and teeth. Given the rarity of this condition (prevalence of 1 in 1,000,000), the variable phenotype and lack of correlation to specific genotypes, coordinated clinical research is needed to better understand CCD. The purpose of this project is to: investigate the genetic makeup and phenotypic expression of CCD, understand the quality of life for patients with this diagnosis, and further identify the multidimensional healthcare needs of these patients. Participation involves completion of a survey to ascertain medical history and quality of life, a physical exam and research whole exome sequencing from a blood or saliva sample. The goal of this research is to elucidate critical pathways in skeletal and dental development and improve quality of life for CCD patients through the standardization and optimization of timely diagnosis and multidisciplinary care.
Enrollment
Sex
Volunteers
Inclusion criteria
- Patient has molecular or clinical diagnosis of CCD
- Caregiver or parent of patient with CCD.
Exclusion criteria
- Patient does not have CCD
- Patient over 18 but cannot consent for themselves
- Not fluent in English.
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal